Palisade Bio Gains FDA IND Clearance for PALI-2108
DENVER, Colo. — September 22, 2026 Palisade Bio announced that the U.S. Food and Drug Administration has cleared the...
Crohn’s Disease
Advertisement
Lupin Wins FDA Approval for Modafinil Tablets in U.S.
Mumbai, India, and Naples, Florida, USA, September 4, 2026 Lupin Limited has received U.S. Food and Drug Administration (FDA)...
Samsung Bioepis Gains Japan Approval for Ustekinumab Biosimilar
Incheon, South Korea, September 3, 2026 Samsung Bioepis has announced that its ustekinumab biosimilar has received marketing approval in...
AbbVie Submits SKYRIZI SC Induction Application to EMA
North Chicago, Illinois, United States, Aug. 27, 2026 AbbVie has submitted a regulatory application to the European Medicines Agency...
Palisade Bio Advances PALI-2108 Into Phase 2 IBD Trials
DENVER, Colorado, August 10, 2026 Palisade Bio, Inc. announced its second-quarter 2026 financial results and provided a business update...
Advertisements
Fresenius Kabi’s Vedolizumab Biosimilar Accepted for FDA and EMA Review
BAD HOMBURG, Germany, July 31, 2026 Fresenius Kabi, an operating company of Fresenius, announced that both the U.S. Food...
Polpharma Biologics Secures FDA and EMA Review for PB016
ROTKREUZ, Switzerland, July 31, 2026 Polpharma Biologics International AG announced that the U.S. Food and Drug Administration (FDA) and...
Caldera, Synlogic Unite in $278M Biotech Merger
CAMBRIDGE, Mass., July 29, 2026 Synlogic, Inc. and Caldera Therapeutics, Inc. have entered into a definitive all-stock merger agreement...
Palisade Bio Receives FDA IND Clearance for PALI-2108
DENVER, Colo., June 29, 2026 Palisade Bio, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared...
Abivax Reports Positive Phase 3 Obefazimod Maintenance Data
PARIS, France, June 29, 2026 Abivax SA announced positive topline results from ABTECT Maintenance Part 2, the supplemental portion...
Advertisement
